BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 5241474)

  • 1. Effects of phenformin on insulin reserve and release.
    Boshell BR; Roddam RF; McAdams GL
    Ann N Y Acad Sci; 1968 Mar; 148(3):756-67. PubMed ID: 5241474
    [No Abstract]   [Full Text] [Related]  

  • 2. Phenformin and insulin secretion.
    Boshell BR; Chandalia HB; McAdams GL; Roddam RF
    Postgrad Med J; 1969 May; 45():38-47. PubMed ID: 5364313
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined sulfonylurea-phenformin therapy of the dysinsulinism of early diabetes mellitus.
    Horton ES; Sheikholislam BM; Bressler R
    Ann N Y Acad Sci; 1968 Mar; 148(3):778-86. PubMed ID: 4872311
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of phenformin on glucose-insulin interrelationships.
    Stout RW; Brunzell JD; Bierman EL; Porte D
    Diabetes; 1974 Jul; 23(7):624-30. PubMed ID: 4841569
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanism of action of phenethylbiguanide (Phenformin) in man IV. Effect of phenethylbiguanide (PBG) on glucose tolerance and lactate dynamics in obese nondiabetic and chemical diabetic subjects.
    Cesar FP; Leme CE; Ohnuma LY; Palomino CR; Wajchenberg BL
    Metabolism; 1980 Mar; 29(3):270-8. PubMed ID: 6990168
    [No Abstract]   [Full Text] [Related]  

  • 6. Insulin response to glucose in the presence of oral hypoglycemics.
    Arky RA; Abramson EA
    Ann N Y Acad Sci; 1968 Mar; 148(3):768-77. PubMed ID: 5241475
    [No Abstract]   [Full Text] [Related]  

  • 7. Alimentary reactive hypoglycemia: effects of DBI and dilantin on insulin secretion.
    Hofeldt FD; Lufkin EG; Hull SF; Davis JW; Dippe S; Levin S; Forsham PH
    Mil Med; 1975 Dec; 140(12):841-5. PubMed ID: 812019
    [No Abstract]   [Full Text] [Related]  

  • 8. Alimentary hypoglycemia in the absence of gastrointestinal surgery.
    Permutt MA; Kelly J; Berstein R; Alpers DH; Siegel BA; Kipnis DM
    N Engl J Med; 1973 Jun; 288(23):1206-10. PubMed ID: 4700554
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of long-term tolbutamide treatment on glucose tolerance and insulin secretion in maturity-onset diabetes without obesity.
    Lauvaux JP; Mandart G; Heymans G; Ooms HA
    Horm Metab Res; 1972 Mar; 4(2):58-62. PubMed ID: 5028221
    [No Abstract]   [Full Text] [Related]  

  • 10. [Estimation of insulin efficacy in obesity by the response of blood insulin and glucose to intravenous tolbutamide].
    Vague P; Depieds R; Boeuf G; Leroy C; Perrimond D; Codaccioni JL; Vague J
    Ann Endocrinol (Paris); 1966; 27(6):820-9. PubMed ID: 5973133
    [No Abstract]   [Full Text] [Related]  

  • 11. [Insulin secretion in the clinical stages of diabetes (with glucose tolerance test abnormalities)].
    Vague P; Vague J
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):55-65. PubMed ID: 4605752
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of phenethylbiguanide on the behavior of blood insulin in obesity and aketosic fat diabetes].
    Fratino P; Maggi G; Rodari T
    Clin Ter; 1969 Jun; 49(5):449-59. PubMed ID: 5386745
    [No Abstract]   [Full Text] [Related]  

  • 13. Inter-relationship between insulin secretion and plasma free fatty acid and triglyceride transport kinetics in maturity onset diabetes and the effect of phenethylbiguanide (phenformin).
    Kissebah AH; Adams PW; Wynn V
    Diabetologia; 1974 Apr; 10(2):119-30. PubMed ID: 4844187
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of phenformin on peripheral glucose utilization and insulin action in obesity and diabetes mellitus.
    Butterfield WJ
    Ann N Y Acad Sci; 1968 Mar; 148(3):724-33. PubMed ID: 5242146
    [No Abstract]   [Full Text] [Related]  

  • 15. Diabetes mellitus and obesity: phenformin hydrochloride as a research tool. Concluding remarks.
    Danowski TS
    Ann N Y Acad Sci; 1968 Mar; 148(3):958-62. PubMed ID: 5241487
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum immunoreactive insulin response to oral glucose and intravenous sodium tolbutamide administration in relation to obesity.
    Devrim S; Koniçe M; Sencer E; Molvalìlar S; Alp H
    Isr J Med Sci; 1972 Jun; 8(6):815-20. PubMed ID: 5051802
    [No Abstract]   [Full Text] [Related]  

  • 17. [Insulin release impairment in IGT].
    Kikuchi M
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():107-13. PubMed ID: 15779354
    [No Abstract]   [Full Text] [Related]  

  • 18. Maximum stimulation of insulin secretion in children with chemical diabetes and obesity.
    Castells S; Avruskin T; Reddy CM; Hashemi SE
    Am J Med Sci; 1976; 271(1):35-9. PubMed ID: 943938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blood insulin and diabetes. I. Method of study--normal subjects--diabetic disease].
    Duprey J; Lubetzki J
    Pathol Biol (Paris); 1971 Mar; 19(5):311-31. PubMed ID: 4929994
    [No Abstract]   [Full Text] [Related]  

  • 20. [Metabolic control and insulin secretion in diabetic patients treated with glibenclamide-phenformin combination].
    Fedele D; Tiengo A; Muggeo M; Garotti C; Crepaldi G
    Clin Ter; 1975 Nov; 75(3):273-80. PubMed ID: 819203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.